Concepedia

Connie Lee Batlevi

CL

Statistics

Publications

55

Citations

3.7K

H-Index

30

Active since

2016

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Sylvester Comprehensive Cancer Center

Washington University in St. Louis

The University of Texas MD Anderson Cancer Center

Connie Lee Batlevi is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and immunotherapy.

ORCID

Top concepts

Publications per year

2016–2025

55

Publications

55

Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial

Franck Morschhauser, Hervé Tilly, Aristeidis Chaidos et al. · The Lancet Oncology · 2020 · 556 citations · Full text

, , +7

Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies

Tania Jain, Andrea Knežević, Martina Pennisi et al. · Blood Advances · 2020 · 252 citations · Full text

Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma

Kitsada Wudhikarn, M. Lia Palomba, Martina Pennisi et al. · Blood Cancer Journal · 2020 · 249 citations · Full text

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

Connie Lee Batlevi, Fushen Sha, Anna Alperovich et al. · Blood Cancer Journal · 2020 · 185 citations · Full text

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder et al. · Journal of Clinical Oncology · 2021 · 183 citations · Full text

1–5 of 55